| Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily, V Baldo, ... The Lancet 394 (10197), 497-509, 2019 | 949 | 2019 |
| Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis M Drolet, É Bénard, MC Boily, H Ali, L Baandrup, H Bauer, S Beddows, ... The Lancet infectious diseases 15 (5), 565-580, 2015 | 882 | 2015 |
| Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study T Palmer, L Wallace, KG Pollock, K Cuschieri, C Robertson, K Kavanagh, ... bmj 365, 2019 | 289 | 2019 |
| Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study K Kavanagh, KG Pollock, K Cuschieri, T Palmer, RL Cameron, C Watt, ... The Lancet infectious diseases 17 (12), 1293-1302, 2017 | 276 | 2017 |
| Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types K Kavanagh, KGJ Pollock, A Potts, J Love, K Cuschieri, H Cubie, ... British journal of cancer 110 (11), 2804-2811, 2014 | 229 | 2014 |
| Reduction of low-and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland KGJ Pollock, K Kavanagh, A Potts, J Love, K Cuschieri, H Cubie, ... British journal of cancer 111 (9), 1824-1830, 2014 | 198 | 2014 |
| Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009–2013 RL Cameron, K Kavanagh, J Pan, J Love, K Cuschieri, C Robertson, ... Emerging infectious diseases 22 (1), 56, 2016 | 147 | 2016 |
| Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes D Mesher, K Soldan, M Lehtinen, S Beddows, M Brisson, JML Brotherton, ... Emerging infectious diseases 22 (10), 1732, 2016 | 105 | 2016 |
| The burden of HPV-associated anogenital cancers K Wakeham, K Kavanagh Current oncology reports 16, 1-11, 2014 | 98 | 2014 |
| Achieving high and equitable coverage of adolescent HPV vaccine in Scotland K Sinka, K Kavanagh, R Gordon, J Love, A Potts, M Donaghy, ... J Epidemiol Community Health 68 (1), 57-63, 2014 | 96 | 2014 |
| Impact of healthcare-associated infection on length of stay S Stewart, C Robertson, J Pan, S Kennedy, L Haahr, S Manoukian, ... Journal of Hospital Infection 114, 23-31, 2021 | 93 | 2021 |
| Nasal swab screening for methicillin-resistant Staphylococcus aureus—how well does it perform? A cross-sectional study A Matheson, P Christie, T Stari, K Kavanagh, IM Gould, R Masterton, ... Infection Control & Hospital Epidemiology 33 (8), 803-808, 2012 | 83 | 2012 |
| Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial B Guthrie, K Kavanagh, C Robertson, K Barnett, S Treweek, D Petrie, ... bmj 354, 2016 | 79 | 2016 |
| Epidemiology of healthcare-associated infection reported from a hospital-wide incidence study: considerations for infection prevention and control planning S Stewart, C Robertson, J Pan, S Kennedy, S Dancer, L Haahr, ... Journal of Hospital Infection 114, 10-22, 2021 | 77 | 2021 |
| HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study TJ Palmer, M McFadden, KGJ Pollock, K Kavanagh, K Cuschieri, ... British journal of cancer 114 (5), 582-589, 2016 | 74 | 2016 |
| HPV status and favourable outcome in vulvar squamous cancer K Wakeham, K Kavanagh, K Cuschieri, D Millan, KG Pollock, S Bell, ... International journal of cancer 140 (5), 1134-1146, 2017 | 71 | 2017 |
| Head and neck cancer risk calculator (HaNC‐RC)—V. 2. Adjustments and addition of symptoms and social history factors T Tikka, K Kavanagh, A Lowit, P Jiafeng, H Burns, IJ Nixon, V Paleri, ... Clinical Otolaryngology 45 (3), 380-388, 2020 | 69 | 2020 |
| COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records JH Thygesen, C Tomlinson, S Hollings, MA Mizani, A Handy, A Akbari, ... The Lancet Digital Health 4 (7), e542-e557, 2022 | 58 | 2022 |
| Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010 AJ Elliot, N Singh, P Loveridge, S Harcourt, S Smith, R Pnaiser, ... Eurosurveillance 15 (23), 19583, 2010 | 57 | 2010 |
| The impact of the COVID-19 pandemic on pregnancy planning behaviors AC Flynn, K Kavanagh, AD Smith, L Poston, SL White Women's Health Reports 2 (1), 71-77, 2021 | 56 | 2021 |
